Loading, please wait ...

News Analytics

Seelos Therapeutics has announced plans to start patient dosing in a pivotal Phase 2b/3 trial testing its experimental therapy SLS-005 (trehalose), designed to prevent protein clumping in cells, in adults with amyotrophic lateral sclerosis (ALS) by the close of September. The study is part of the HEALEY ALS Platform Trial (NCT04297683), the first multi-regimen trial in ALS, and will mark ...

The Angle

Subject Matter

  • Science and technology 63.38%
  • Healthcare 36.62%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction






Dimensions/Depth Chart

If you find a dimension intereseting, we recommend you pick up one or two facts that you find intriguing and place them into your memory. That way you will have 2nd degree information about the topic if it comes up in conversation.

Accordingly, you can do the same with others as well.